Article

In-silico analysis of potential interaction of drugs and the SARS-CoV-2 spike protein

2020-05-21

Abstract excerpt

The world is suffering its deadly pandemic in decades from Corona virus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Till the end of April, 2020, the death toll rose to more than 2 lacs worldwide (224 301, on May 1 st ), affecting 215 countries (source: WHO). Since the invention of a new drug or vaccine takes time, drug repurposing is one of the avenues. Keeping...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a87e6ccd-8513-57a6-9d90-ef6de1cca087
DOI: 10.21203/rs.3.rs-30401/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

In-silico analysis of potential interaction of drugs and the SARS-CoV-2 spike proteinDOI 10.21203/rs.3.rs-30401/v1Read

Virtual screening and molecular dynamics simulations provide insight into repurposing drugs against SARS-CoV-2 variants Spike protein/ACE2 interfaceSemantic proximity Read

In Silico Discovery and Evaluation of Inhibitors of the SARS-CoV-2 Spike Protein–HSPA8 Complex Towards Developing COVID-19 Therapeutic DrugsSemantic proximity Read

In silico screening of known small molecules to bind ACE2 specific RBD on Spike glycoprotein of SARS-CoV-2 for repurposing against COVID-19Semantic proximity Read

Structural Comparison and Drug Screening of Spike Proteins of Ten SARS-CoV-2 VariantsSemantic proximity Read

Structural insights into spike protein and its natural variants of SARS-CoV-2 found on Mexican population.Semantic proximity Read

Integrative structural studies of the SARS-CoV-2 spike protein during the fusion process (2022)Semantic proximity Read

Molecular-Level Anatomy of SARS-CoV-2 for the Battle against the COVID-19 PandemicSemantic proximity Read

Research Progress on Spike-Dependent SARS-CoV-2 Fusion Inhibitors and Small Molecules Targeting the S2 Subunit of SpikeSemantic proximity Read

A strategy to optimize the peptide-based inhibitors against different mutants of the spike protein of SARS-CoV-2Semantic proximity Read

Structural Analysis And Molecular Characteristics of SARSCoV-2 Spike Protein Following S494P Point Mutation: Molecular Dynamics StudySemantic proximity Read

Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV SpikeSemantic proximity Read

Structure of Human TMPRSS2 in Complex with SARS-CoV-2 Spike Glycoprotein and Implications for Potential TherapeuticsSemantic proximity Read